![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
This acquisition brings together globally recognized vitamin K2 brands vitaMK7® and MenaQ7® and allows Gnosis by Lesaffre to offer to the market the most complete portfolio of solutions, adapted to each market need and able to satisfy all customers.
Lead Product(s): Vitamin K2
Therapeutic Area: Musculoskeletal Product Name: MenaQ7
Highest Development Status: Phase IVProduct Type: Small molecule
Partner/Sponsor/Collaborator: Gnosis by Lesaffre
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition May 25, 2021